1-2 of 2
Troy Sneed, Research Nurse
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Bayesian Phase II Randomized Trial of Azacitidine Versus Azacitidine + Vorinostat in Patients with Newly Diagnosed AML or High-Risk MDS with Poor Performance Status, Organ Dysfunction, or Other Comorbidities

Guillermo Garcia-Manero, MD, Xuelin Huang, PhD, Monica Cabrero, MD, Courtney D. DiNardo, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Gautam Borthakur, MD, William G Wierda, MDPhD, Tapan Kadia, MD, Yesid Alvarado, MD, Jorge E. Cortes, MD, Nitin Jain, MD, Farhad Ravandi, MD, Elias Jabbour, MD, Mark Brandt, Troy Sneed, Research Nurse, Victoria Sukholutsky, Sherry Pierce, BSN, BA, Zachary Bohannan, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2014) 124 (21): 3277.
https://doi.org/10.1182/blood.V124.21.3277.3277
Published: 2014
Journal Articles

Azacytidine and Vorinostat in Patients with Chronic Lymphocytic Leukemia (CLL) Diagnosed with Therapy-Related Myelodysplastic Syndromes/Acute Myeloid Leukemia (t-MDS/AML)

Yesid Alvarado, MD, Michael J Keating, MBBS, Susan O'Brien, MD, Hagop M. Kantarjian, MD, William G. Wierda, MD PhD, Troy Sneed, Research Nurse, Nitin Jain, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2014) 124 (21): 5627.
https://doi.org/10.1182/blood.V124.21.5627.5627
Published: 2014